Division of Pediatric Urology, Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Pediatric Urology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, 30328, USA.
Pediatr Nephrol. 2022 Jun;37(6):1339-1345. doi: 10.1007/s00467-021-05271-w. Epub 2021 Oct 30.
Posterior urethral valve (PUV) is a leading cause of chronic kidney failure in children. Studies have shown that a creatinine nadir above historical cutoff values of 0.8 or 1.0 mg/dL correlates with worse kidney outcomes. The ability to use nadir creatinine more discriminately as a test of kidney outcomes is otherwise limited.
We performed a retrospective review of 102 infants treated with primary valve ablation prior to 1 year of age. Patient factors including creatinine at presentation (Cr-P), nadir within 6 weeks after ablation (Cr-6 W), and nadir within 1 year after ablation (Cr-1Y) were assessed as predictors of final chronic kidney disease (CKD) severity. An optimal threshold for four CKD levels was defined in incremental fashion using binary outcome with receiver operating characteristic (ROC). Multivariable logistic regression models compared Cr-P, Cr-6 W, and Cr-1Y while adjusting for patient factors.
Boys were ablated at mean age of 36.3 days and followed for 6.6 years (± 3.7). When compared to other demographics, only creatinine remained independently predictive of CKD outcomes on multivariable analysis. ROC analysis demonstrated excellent diagnostic accuracy for Cr-6 W and Cr-1Y (p < 0.001) and acceptable accuracy for Cr-P (p < 0.005). Using the Cr-6 W and Cr-1Y models, high sensitivity and specificity creatinine nadir cutoffs were determined to predict each CKD outcome.
The severity of childhood CKD can be predicted with high accuracy using the creatinine nadir within 6 weeks of ablation. The cutoff values described can be incorporated into a clinical setting for patient counseling and individual risk stratification.
后尿道瓣膜(PUV)是儿童慢性肾衰竭的主要原因。研究表明,肌酐谷值高于历史截断值 0.8 或 1.0mg/dL 与更差的肾脏结局相关。否则,肌酐谷值作为肾脏结局测试的区分能力有限。
我们对 102 例在 1 岁前接受原发性瓣膜消融治疗的婴儿进行了回顾性研究。评估了患者的相关因素,包括就诊时的肌酐(Cr-P)、消融后 6 周内的肌酐谷值(Cr-6W)和消融后 1 年内的肌酐谷值(Cr-1Y),作为最终慢性肾脏病(CKD)严重程度的预测因素。使用二元结果以接收者操作特征(ROC)的方式逐步定义 4 个 CKD 水平的最佳阈值。多元逻辑回归模型比较了 Cr-P、Cr-6W 和 Cr-1Y,并调整了患者因素。
男孩在平均 36.3 天的年龄进行消融,并随访 6.6 年(±3.7)。与其他人口统计学相比,只有肌酐在多变量分析中仍然是 CKD 结局的独立预测因素。ROC 分析表明,Cr-6W 和 Cr-1Y 的诊断准确性非常高(p<0.001),Cr-P 的准确性也可以接受(p<0.005)。使用 Cr-6W 和 Cr-1Y 模型,确定了预测每个 CKD 结局的高灵敏度和特异性肌酐谷值截止值。
消融后 6 周内的肌酐谷值可以高度准确地预测儿童 CKD 的严重程度。所描述的截止值可以纳入临床环境,用于患者咨询和个体风险分层。